Skip to main content
Erschienen in: Diabetologia 1/2011

01.01.2011 | Article

Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?

verfasst von: P. Ramakant, A. K. Verma, R. Misra, K. N. Prasad, G. Chand, A. Mishra, G. Agarwal, A. Agarwal, S. K. Mishra

Erschienen in: Diabetologia | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We studied the bacterial aetiology and antibiotic sensitivity pattern of diabetic foot ulcers in India.

Methods

Records of 447 hospitalised patients between 1991 and 2008 were retrospectively analysed between two time periods (before and after 1999) to compare bacterial aetiology and antimicrobial sensitivity patterns. The first three consecutive cultures from the same wound during treatment were evaluated.

Results

Of 1,632 cultures, 66% were polymicrobial, 23% monomicrobial and 11% sterile. In the monomicrobial group, 14% (n = 228) of cultures were Gram-negative, whereas 9% (n = 147) were Gram-positive. The most common pathogens in the first culture were Pseudomonas aeruginosa (20.1%), Staphylococcus aureus (17.2%) and Escherichia coli (16.3%). Results for the third cultures showed persistence of P. aeruginosa (15.3%) and E. coli (14.2%). Gram-negative isolates dominated over Gram-positive ones (25.3% vs 15.1%, p < 0.05). Antibiotic sensitivity patterns before and after 1999 were: piperacillin–tazobactam 74% vs 66% (p < 0.005), imipenem 77% vs 85% (NS), cefoperazone–sulbactam 47% vs 44% (p < 0.005), amikacin 62% vs 78% (NS), ceftriaxone 41% vs 36% (p < 0.005), amoxicillin–clavulanate 51% vs 43% (p < 0.05) and clindamycin 43% vs 36% (p < 0.005), respectively.

Conclusions/interpretation

Unlike in the West, in India Gram-negative bacteria were found to have always been dominant in the wounds of patients with diabetic foot infections. Infection with polymicrobial multidrug-resistant Gram-negative bacilli is common. The policy of empirical antimicrobial therapy at tertiary care needs to be changed.
Literatur
1.
Zurück zum Zitat Lipsky BA (2007) Emperical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? Clin Microbiol Infect 13:351–353CrossRefPubMed Lipsky BA (2007) Emperical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? Clin Microbiol Infect 13:351–353CrossRefPubMed
2.
Zurück zum Zitat Lipsky BA, Anthony R, Berendt H et al (2004) Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39:885–891CrossRefPubMed Lipsky BA, Anthony R, Berendt H et al (2004) Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39:885–891CrossRefPubMed
3.
Zurück zum Zitat Nicolau DP, Stein GE (2010) Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics. J Am Podiatr Med Assoc 100:52–63PubMed Nicolau DP, Stein GE (2010) Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics. J Am Podiatr Med Assoc 100:52–63PubMed
4.
Zurück zum Zitat Dang CN, Prasad YD, Boulton AJ, Jude EB (2003) Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20:159–161CrossRefPubMed Dang CN, Prasad YD, Boulton AJ, Jude EB (2003) Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20:159–161CrossRefPubMed
5.
Zurück zum Zitat Citron DM, Goldstein EJC, Merriam CV, Lipsky BA, Abramson MA (2007) Bacteriology of moderate to severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 45:2819–2828CrossRefPubMed Citron DM, Goldstein EJC, Merriam CV, Lipsky BA, Abramson MA (2007) Bacteriology of moderate to severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 45:2819–2828CrossRefPubMed
6.
Zurück zum Zitat Lipsky BA, Pecoraro RE, Wheat LJ (1990) The diabetic foot: soft tissue and bone infection. Infect Dis Clin North Am 4:409–432PubMed Lipsky BA, Pecoraro RE, Wheat LJ (1990) The diabetic foot: soft tissue and bone infection. Infect Dis Clin North Am 4:409–432PubMed
7.
Zurück zum Zitat Grayson ML (1995) Diabetic foot infections: antimicrobial therapy. Infect Dis Clin North Am 9:143–161PubMed Grayson ML (1995) Diabetic foot infections: antimicrobial therapy. Infect Dis Clin North Am 9:143–161PubMed
8.
Zurück zum Zitat Joseph WS, Axler DA (1990) Microbiology and antimicrobial therapy of diabetic foot infections. Clin Podiatr Med Surg 7:467–481PubMed Joseph WS, Axler DA (1990) Microbiology and antimicrobial therapy of diabetic foot infections. Clin Podiatr Med Surg 7:467–481PubMed
9.
Zurück zum Zitat Goldstein EJ, Citron DM, Nesbit CA (1996) Diabetic foot infections: bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diab Care 19:638–641CrossRef Goldstein EJ, Citron DM, Nesbit CA (1996) Diabetic foot infections: bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diab Care 19:638–641CrossRef
10.
Zurück zum Zitat Sims D, Keating SE, DeVincentis AF (1984) Bacteriology of diabetic foot ulcers. J Foot Surg 23:149–151PubMed Sims D, Keating SE, DeVincentis AF (1984) Bacteriology of diabetic foot ulcers. J Foot Surg 23:149–151PubMed
11.
Zurück zum Zitat Jones EW, Edwards R, Finch R, Jeffcoate WJ (1985) A microbiological study of diabetic foot lesions. Diabet Med 2:213–215CrossRefPubMed Jones EW, Edwards R, Finch R, Jeffcoate WJ (1985) A microbiological study of diabetic foot lesions. Diabet Med 2:213–215CrossRefPubMed
12.
Zurück zum Zitat Nelson SB (2009) Management of diabetic foot infections in an era of increasing microbial resistance. Curr Infect Dis Rep 11:375–382CrossRefPubMed Nelson SB (2009) Management of diabetic foot infections in an era of increasing microbial resistance. Curr Infect Dis Rep 11:375–382CrossRefPubMed
13.
Zurück zum Zitat Smith RG (2003) Validation of Wagner’s classification: a literature review. Ostomy Wound Manage 49:54–62PubMed Smith RG (2003) Validation of Wagner’s classification: a literature review. Ostomy Wound Manage 49:54–62PubMed
14.
Zurück zum Zitat Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ (2001) A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diab Care 24:84–88CrossRef Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ (2001) A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diab Care 24:84–88CrossRef
15.
Zurück zum Zitat Clinical and Laboratory Standards Institute (2007) M100-S17. Performance standards for antimicrobial susceptibility testing. 16th informational supplement. Clinical and Laboratory Standards Institute, Wayne Clinical and Laboratory Standards Institute (2007) M100-S17. Performance standards for antimicrobial susceptibility testing. 16th informational supplement. Clinical and Laboratory Standards Institute, Wayne
16.
Zurück zum Zitat Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R (2006) A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diab Care 29:1727–1732CrossRef Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R (2006) A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diab Care 29:1727–1732CrossRef
17.
Zurück zum Zitat Shankar EM, Mohan V, Premlatha G, Srinivasan RS, Usha AR (2006) Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med 16:567–570CrossRef Shankar EM, Mohan V, Premlatha G, Srinivasan RS, Usha AR (2006) Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med 16:567–570CrossRef
18.
Zurück zum Zitat Raja NS (2007) Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. J Microbiol Immunol Infect 40:39–44PubMed Raja NS (2007) Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. J Microbiol Immunol Infect 40:39–44PubMed
19.
Zurück zum Zitat Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A (2004) Fungal peritonitis in patients on continous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 48:96–101CrossRefPubMed Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A (2004) Fungal peritonitis in patients on continous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 48:96–101CrossRefPubMed
20.
Zurück zum Zitat Bansal E, Garg A, Bhatia S, Attri AK, Chander J (2008) Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol 51:123–126 Bansal E, Garg A, Bhatia S, Attri AK, Chander J (2008) Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol 51:123–126
21.
Zurück zum Zitat Kumar MS, Lakshmi V, Rajagopalan R (2006) Occurrence of extended spectrum beta lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Indian J Med Microbiol 24:208–211PubMed Kumar MS, Lakshmi V, Rajagopalan R (2006) Occurrence of extended spectrum beta lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Indian J Med Microbiol 24:208–211PubMed
22.
Zurück zum Zitat Mohanty S, Kapil A, Dhawan B, Das BK (2004) Bacteriological and antimicrobial susceptibility profile of soft tissue infections from Northern India. Indian J Med Sci 58:10–15PubMed Mohanty S, Kapil A, Dhawan B, Das BK (2004) Bacteriological and antimicrobial susceptibility profile of soft tissue infections from Northern India. Indian J Med Sci 58:10–15PubMed
23.
Zurück zum Zitat Patel V, Vaidya R, Naik D, Borker P (2005) Irrational drug use in India: a prescription survey from Goa. J Postgrad Med 51:9–12PubMed Patel V, Vaidya R, Naik D, Borker P (2005) Irrational drug use in India: a prescription survey from Goa. J Postgrad Med 51:9–12PubMed
24.
Zurück zum Zitat Sharma R, Sharma CL, Kapoor B (2005) Antibacterial resistance: current problems and possible solutions. Indian J Med Sci 59:120–129CrossRefPubMed Sharma R, Sharma CL, Kapoor B (2005) Antibacterial resistance: current problems and possible solutions. Indian J Med Sci 59:120–129CrossRefPubMed
25.
Zurück zum Zitat Dallenne C, Costa AD, Decre D, Favier C, Guillaume A (2010) Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65:490–495CrossRefPubMed Dallenne C, Costa AD, Decre D, Favier C, Guillaume A (2010) Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65:490–495CrossRefPubMed
26.
Zurück zum Zitat Senneville E, Melliez H, Beltrand E, Legout E, Valette M, Cazaubiel M (2006) Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 42:57–62CrossRefPubMed Senneville E, Melliez H, Beltrand E, Legout E, Valette M, Cazaubiel M (2006) Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 42:57–62CrossRefPubMed
27.
Zurück zum Zitat Pellizzer G, Strazzabosco M, Presi S et al (2001) Deep tissue biopsy vs superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med 18:822–827CrossRefPubMed Pellizzer G, Strazzabosco M, Presi S et al (2001) Deep tissue biopsy vs superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med 18:822–827CrossRefPubMed
28.
Zurück zum Zitat Slater RA, Lazarovitch T, Boldur I et al (2004) Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med 21:705–709CrossRefPubMed Slater RA, Lazarovitch T, Boldur I et al (2004) Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med 21:705–709CrossRefPubMed
Metadaten
Titel
Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?
verfasst von
P. Ramakant
A. K. Verma
R. Misra
K. N. Prasad
G. Chand
A. Mishra
G. Agarwal
A. Agarwal
S. K. Mishra
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 1/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1893-7

Weitere Artikel der Ausgabe 1/2011

Diabetologia 1/2011 Zur Ausgabe

List of Referees

List of Referees

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.